Semaslim Injection 0.5 mg/0.5 ml contains Semaglutide, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist used in the management of type 2 diabetes mellitus and, in selected patients, for chronic weight management. It helps improve blood sugar control, reduces appetite, and supports sustained weight reduction when combined with diet and exercise.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Semaglutide 0.5 mg per 0.5 ml

Indications

Semaslim Injection is indicated for:

• Type 2 diabetes mellitus (as an adjunct to diet and exercise)
• Weight management in overweight or obese adults (as prescribed by a physician)
• Reduction of cardiovascular risk in selected high-risk diabetic patients

Mechanism of Action

Semaglutide mimics the action of the natural GLP-1 hormone, leading to:

• Increased insulin secretion in response to high blood glucose
• Decreased glucagon secretion
• Slowed gastric emptying
• Reduced appetite and caloric intake

These combined effects improve glycemic control and promote weight loss.

Dosage and Administration

• Administered as a subcutaneous injection once weekly or as directed by a physician
• The 0.5 mg dose is commonly used as a maintenance or dose-escalation step after initial therapy
• Inject into abdomen, thigh, or upper arm
• Rotate injection sites to avoid irritation
• Follow proper medical training for self-injection

Benefits

• Improves long-term blood glucose control
• Supports significant and sustained weight reduction
• Reduces appetite and food cravings
• May lower risk of cardiovascular complications in diabetic patients
• Convenient once-weekly dosing

Possible Side Effects

Common side effects may include:

• Nausea
• Vomiting
• Diarrhea or constipation
• Abdominal discomfort
• Decreased appetite

Serious side effects:

• Pancreatitis
• Gallbladder disease
• Severe dehydration
• Hypoglycemia (especially with insulin or sulfonylureas)

Seek immediate medical attention if severe symptoms occur.

Precautions and Warnings

• Not indicated for type 1 diabetes
• Use with caution in patients with a history of pancreatitis
• Not recommended during pregnancy or breastfeeding unless clearly necessary
• Regular blood glucose monitoring is advised
• May delay gastric emptying and affect absorption of oral medications

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

Semaslim Injection may interact with:

• Insulin and other antidiabetic medications
• Oral drugs affected by gastric emptying rate
• Other weight management therapies

Always inform your healthcare provider about all current medications.

Storage

• Store in a refrigerator at 2°C to 8°C
• Do not freeze
• Protect from light
• Keep out of reach of children.